| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_fe62dd734dd9257927bf8ed2a09bfb5d |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P37-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-41 |
| filingDate |
1983-07-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
1991-08-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_466f949910840d58a364674996d30659
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_096354ed1fb653035ffaab9fd21c8c08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7fad69dbb9f569abf3e5d9a05cc2484c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d9d947dda668721db1d7fa783b18b2c3
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ae49760dcfcf10d650e739009ecbfc71
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_610e642893e69ef4cd958e40212c836c |
| publicationDate |
1991-08-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
SU-1673118-A1 |
| titleOfInvention |
Agent for rising immune reactivity of human organism |
| abstract |
The invention relates to the treatment of immunodeficiency states. The purpose of the invention is to increase the effect of immunostimulation in secondary immunodeficiency states. For this, the patient is administered with 0.25 g of boemityl 1 time per day for 5-7 days, and, if necessary, again. The use of the immunostimulating effect of boemitil in its use reduces the duration of treatment of immunodeficiency by 1.5-2 times. The drug is successfully used in patients with recurrent mug and viral hepatitis. |
| priorityDate |
1983-07-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |